Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05609435 · ClinicalTrials.gov registry record · NA
Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT05609435 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 104 participants.
The verdict
NCT05609435, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
This study tests a novel intervention designed to optimize needed survivorship care for low-risk breast cancer survivors while reducing burdensome care with limited health benefits. This study examines whether the intervention, titled REASSURE, improves survivors' preparedness for survivorship. Up to 110 participants will be on study for up to 18 months.
Interventions
- OTHER REASSURE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2022-11-16 |
| Est. Completion | 2026-01-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05609435
The ClinicalTrials.gov registry entry for NCT05609435 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which REASSURE is the first listed.
NCT05609435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05609435 about?
NCT05609435 is a clinical study titled "Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer". This study tests a novel intervention designed to optimize needed survivorship care for low-risk breast cancer survivors while reducing burdensome care with limited health benefits. This study examines whether the intervention, titled REASSURE, improves survivors' preparedness for survivorship. Up t...
What is the current status of trial NCT05609435?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2022-11-16. Estimated completion is 2026-01-27.
What interventions are being tested in trial NCT05609435?
The interventions under investigation include: REASSURE (OTHER).
Who is sponsoring clinical trial NCT05609435?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.